A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Fatima on 2022/10/20

Curated date: 2022/08/28

Curator: Mary Bearkland

Revision editor(s): WikiWorks, Fatima, Rimsha, Mary Bearkland, Peace Sandy

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Colorectal adenocarcinoma adenocarcinoma of large bowel,adenocarcinoma of large intestine,adenocarcinoma of the large bowel,adenocarcinoma of the large intestine,colorectal (colon or rectal) adenocarcinoma,colorectal adenocarcinoma,colorectum adenocarcinoma,large bowel adenocarcinoma,large intestine adenocarcinoma,Colorectal adenocarcinoma
Group 0 name Corresponds to the control (unexposed) group for case-control studies
healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
colorectal cancer patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
diagnosed of colorectal cancer by colonoscopy and histopathology
Group 0 sample size Number of subjects in the control (unexposed) group
20
Group 1 sample size Number of subjects in the case (exposed) group
44
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
1 month

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
4

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
decreased

Signature 1

Reviewed Marked as Reviewed by Fatima on 2022/10/20

Curated date: 2022/08/29

Curator: Mary Bearkland

Revision editor(s): Mary Bearkland

Source: Figures 4b

Description: Fig. 4 Difference of fecal microbiota in CRC patients and HC. b. LDA score computed from features differentially abundant in CRC and HC fecal samples. The criteria for feature selection were LDA score > 4, p < 0.05, Green and red represent the HC group and CRC group, respectively.

Abundance in Group 1: increased abundance in colorectal cancer patients

NCBI Quality ControlLinks
Bacteroides
Bifidobacterium
Shigella
Escherichia

Revision editor(s): Mary Bearkland

Signature 2

Reviewed Marked as Reviewed by Fatima on 2022/10/20

Curated date: 2022/08/29

Curator: Mary Bearkland

Revision editor(s): Mary Bearkland, Fatima

Source: Figures 4b

Description: Fig. 4 Difference of fecal microbiota in CRC patients and HC. b. LDA score computed from features differentially abundant in CRC and HC fecal samples. The criteria for feature selection were LDA score > 4, p < 0.05, Green and red represent the HC group and CRC group, respectively.

Abundance in Group 1: decreased abundance in colorectal cancer patients

NCBI Quality ControlLinks
Collinsella
Coprobacillus
Faecalibacterium
Romboutsia
Streptococcus
Agathobacter

Revision editor(s): Mary Bearkland, Fatima